Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Hayward Holdings
HAYW
$3.36B
| $21.6M | ﹤0.01% |
1,553,193
+123,478
| +9% | +$1.79M |
|
1602
Oscar Health
OSCR
$8.41B
| $21.6M | ﹤0.01% |
1,645,791
-9,071
| -0.5% | -$135K |
|
1603
DigitalOcean
DOCN
$14.6B
| $21.5M | ﹤0.01% |
644,894
+60,974
| +10% | +$2.38M |
|
1604
Ultragenyx Pharmaceutical
RARE
$2.55B
| $21.5M | ﹤0.01% |
593,121
-20,512
| -3% | -$853K |
|
1605
Omnicell
OMCL
$1.68B
| $21.5M | ﹤0.01% |
613,758
-2,395
| -0.4% | -$95K |
|
1606
Agilon Health
AGL
$1.6B
| $21.4M | ﹤0.01% |
197,583
+15,921
| +9% | +$1.39M |
|
1607
Evertec
EVTC
$1.78B
| $21.3M | ﹤0.01% |
580,500
-47,737
| -8% | -$1.65M |
|
1608
PENN Entertainment
PENN
$2.7B
| $21.3M | ﹤0.01% |
1,306,573
-30,589
| -2% | -$598K |
|
1609
UL Solutions
ULS
$15.8B
| $21.3M | ﹤0.01% |
377,100
+11,776
| +3% | +$625K |
|
1610
Penske Automotive Group
PAG
$14.2B
| $21.2M | ﹤0.01% |
147,470
+1,891
| +1% | +$303K |
|
|
DEA
1611
Easterly Government Properties
DEA
$1.18B
| $21.2M | ﹤0.01% |
800,770
+10,639
| +1% | +$293K |
|
|
SVC
1612
Service Properties Trust
SVC
$1.07B
| $21.2M | ﹤0.01% |
1,625,442
+114,591
| +8% | +$1.55M |
|
1613
Surgery Partners
SGRY
$2.03B
| $21.2M | ﹤0.01% |
890,816
+56,399
| +7% | +$1.33M |
|
1614
Capri Holdings
CPRI
$1.74B
| $21.1M | ﹤0.01% |
1,070,258
+66,173
| +7% | +$1.47M |
|
|
APLS
1615
DELISTED
Apellis Pharmaceuticals
APLS
| $21.1M | ﹤0.01% |
964,499
-32,249
| -3% | -$891K |
|
|
REVG
1616
DELISTED
REV Group
REVG
| $21.1M | ﹤0.01% |
666,758
-29,049
| -4% | -$941K |
|
1617
Photronics
PLAB
$1.93B
| $21M | ﹤0.01% |
1,012,744
+5,162
| +0.5% | +$115K |
|
1618
Addus HomeCare
ADUS
$2.23B
| $21M | ﹤0.01% |
212,115
-12,061
| -5% | -$1.34M |
|
1619
CleanSpark
CLSK
$3.16B
| $21M | ﹤0.01% |
3,117,672
+652,811
| +26% | +$6.18M |
|
1620
Employers Holdings
EIG
$889M
| $20.9M | ﹤0.01% |
413,672
-9,591
| -2% | -$476K |
|
1621
Sweetgreen
SG
$642M
| $20.9M | ﹤0.01% |
835,874
-13,638
| -2% | -$376K |
|
1622
Enterprise Products Partners
EPD
$81.7B
| $20.9M | ﹤0.01% |
612,057
-12,862
| -2% | -$428K |
|
1623
Sonic Automotive
SAH
$2.61B
| $20.9M | ﹤0.01% |
366,730
-13,937
| -4% | -$938K |
|
1624
Riot Platforms
RIOT
$7.76B
| $20.9M | ﹤0.01% |
2,931,774
+146,199
| +5% | +$1.52M |
|
1625
Vanguard Total International Bond ETF
BNDX
$82.2B
| $20.7M | ﹤0.01% |
424,882
-27,394
| -6% | -$1.34M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.